Research progress on probiotics and prebiotics in the treatment of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is estimated to affect approximately 30% of the global population, making it a primary cause of chronic liver disease. The onset and progression of this condition are intricately linked to the intestinal microbiota. Probiotics and prebiotics, by modulating th...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health - Lippincott Williams Wilkins
2025-06-01
|
| Series: | Journal of Nutritional Oncology |
| Online Access: | http://journals.lww.com/10.1097/JN9.0000000000000050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|